About 4 results found for searched term "Quin-C7" (0.068 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4941 | Lomefloxacin | Antibiotic |
| Maxaquin,SC47111A | ||
| Lomefloxacin (SC47111A) is a fluoroquinolone antibiotic. | ||
| M27956 | EPI-743 | Mitochondrial Related |
| α-Tocotrienol quinone; PTC-743; Vatiquinone; NCT04378075 | ||
| EPI-743 (Vatiquinone; α-Tocotrienol quinone; PTC-743; NCT04378075) is a potent cellular oxidative stress protectant, inhibits ferroptosis in cells, which could be used for the study for mitochondrial diseases. EPI-743 is a synthetic analog of vitamin E with oral activity, targets repletion of reduced intracellular glutathione. | ||
| M64406 | NDUFB7 Human Pre-designed siRNA Set | siRNA |
| NADH:ubiquinone oxidoreductase subunit B7 | ||
| Human NDUFB7 Pre-designed siRNA Set contains three designed siRNAs for NDUFB7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Gene ID: 4713 | ||
| M66400 | Quin-C7 | FPR |
| Quin-C7 is an orally active FPR2/ALX antagonist. Quin-C7 binds to the orthosteric ligand-binding pocket of FPR2/ALX, modulates receptor activation, and inhibits pro-inflammatory ERK signaling mediated by serum amyloid A (SAA). Quin-C7 reduces pro-inflammatory mediators TNF-α levels, increases anti-inflammatory IL-10, decreases inflammatory neutrophils and pro-inflammatory M1 macrophages, downregulates ERK1/2 phosphorylation, and upregulates JNK1/2/3 phosphorylation. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
